Epilepsy is a common neurologic disorder yet no treatments aimed at preventing epilepsy have been developed. Several molecules including genes containing cAMP response elements (CREs) in their promoters have been identified that contribute to the development of epilepsy, a process called epileptogenesis. When phosphorylated cAMP response element binding protein (CREB) increases transcription from CRE regulated promoters. CREB phosphorylation is increased in rodent epilepsy models, and in the seizure onset region of humans with medically intractable epilepsy (Rakhade et al., 2005; Lee et al., 2007; Lund et al., 2008). Here we show that mice with decreased CREB levels (CREB αΔ mutants) have a~50% reduction in spontaneous seizures following pilocarpine induced status epilepticus (SE) and require more stimulation to electrically kindle. Following SE, brain derived neurotrophic factor (BDNF) and inducible cAMP early repressor (ICER) mRNAs are differentially up-regulated in the hippocampus and cortex of the CREB αΔ mutants compared to wild-type mice, which may be contributing to differences in the severity of epilepsy. In contrast, we found no difference in KCC2 mRNA levels between the CREB αΔ and wild-type mice after SE. The mechanism by which BDNF and ICER mRNAs increase specifically in the CREB αΔ compared to wild-type mice following SE is not known. We did, however, find an increase in specific cAMP response element modulator (CREM) mRNA transcripts in the CREB αΔ mutants that might be responsible for the differential regulation of BDNF and ICER after SE. Altering CREB activity following a neurologic insult provides a therapeutic strategy for modifying epileptogenesis.
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Introduction
Approximately 1% of the population develops epilepsy with~30% of patients being refractory to currently available medications (ILAE, 1997) . To date, none of the anti-epileptic drugs tested block the development of epilepsy or reverse epileptogenesis (Temkin, 2009) . Changes in gene expression have been identified in the chemoconvulsant or kindling rodent epilepsy models that might contribute to epileptogenesis (Pitkanen et al., 2007) . A better understanding of the gene regulation contributing to epilepotgenesis will hopefully provide new therapeutic strategies focused on blocking epileptogenesis or reversing the epileptic process.
The CRE transcription factor family is composed of multiple members, which share the ability to bind a highly conserved DNA 8-mer (TGACGTCA), a CRE site, found in greater than 4000 gene promoter regions (Zhang et al., 2005) . Among the CRE binding proteins CREB and CREM/ICER are the best characterized in the brain. Binding of CREB primarily promotes transcription and is important for controlling activitydependant processes in neurons such as memory (Lonze and Ginty, 2002) . CREM can either inhibit or promote transcription depending on the exons utilized in the CREM transcript. In contrast, ICER, an isoform of CREM with a unique promoter, suppresses transcription and some forms of memory (Borlikova and Endo, 2009) . Following an episode of SE there is an immediate increase in the active phosphorylated form of CREB and a later sustained increase in ICER, possibly due to increased CREB activity at the CRE sites in the ICER promoter (Lee et al., 2007; Lund et al., 2008; Porter et al., 2008) . Thus, there is a theoretical cascade of initial CRE transcription promotion followed by CRE transcription inhibition, creating a potential feedback loop. In humans with medically intractable epilepsy there is an increase in phosphorylated CREB and gene expression changes consistent with increased CREB regulated transcription in the seizure onset zone (Rakhade et al., 2005) . Activation of CREB and downstream genes appears to be part of both human and rodent epilepsy models.
CRE transcription appears to not only be activated by seizures but can also regulate epileptogenesis. Prolonged CREB activity in the cortex achieved via viral expression of a constituently active CREB caused development of spontaneous seizures (Lopez de Armentia et al., 2007) . Transgenic knockout mice, lacking CREM and ICER develop more severe epilepsy, experiencing 3-fold more seizures following pilocarpine induced SE than wild-type littermates (Porter et al., 2008) . Over expression of ICER in transgenic animals slows the development of seizures induced with electrical stimulation (Kojima Neurobiology of Disease 45 (2012) 253-263 
